Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered ...
HeartSciences is on track for a significant innovation in the healthcare space with the development of its MyoVista® wavECG™ device, which is approaching FDA submission, indicating progress toward ...
The developer of the one of the most widely used wearable ECG monitors has received clearance for two new algorithms that enable users to instantly know if their ECG readings are normal or possibly ...
Please provide your email address to receive an email when new articles are posted on . Algorithms to improve ECG interpretability received FDA clearance. The solution is designed to reduce noise ...
Southlake, TX, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an ...
Hosted on MSN
HeartBeam and Mount Sinai announce strategic AI collaboration to bring clinical-grade heart monitoring into the home
・Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...
New York City-based Icahn School of Medicine at Mount Sinai is partnering with HeartBeam, a medical technology company, to develop and validate a new AI-electrocardiogram algorithm. HeartBeam’s ...
Use of an Apple Watch for heart rhythm monitoring was feasible and picked up more arrhythmias than a standard patch monitor ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results